Ofatumumab (Arzerra®): a Next-Generation Human Therapeutic CD20 Antibody with Potent Complement-Dependent Cytotoxicity
about
Ofatumumab (Arzerra®): a Next-Generation Human Therapeutic CD20 Antibody with Potent Complement-Dependent Cytotoxicity
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2014
@uk
name
Ofatumumab (Arzerra®): a Next- ...... plement-Dependent Cytotoxicity
@en
Ofatumumab
@nl
type
label
Ofatumumab (Arzerra®): a Next- ...... plement-Dependent Cytotoxicity
@en
Ofatumumab
@nl
prefLabel
Ofatumumab (Arzerra®): a Next- ...... plement-Dependent Cytotoxicity
@en
Ofatumumab
@nl
P2093
P2860
P1476
Ofatumumab (Arzerra®): a Next- ...... plement-Dependent Cytotoxicity
@en
P2093
Joost M. Bakker
Margaret A. Lindorfer
Ronald P. Taylor
P2860
P304
P356
10.1002/9783527682423.CH63
P577
2014-08-12T00:00:00Z